Yoshinao Soma Selected Research

Livedo Reticularis

3/2011	Correlation of livedo racemosa, cutaneous inflammatory plaques, and antiphospholipid antibodies in patients with cutaneous polyarteritis nodosa.
5/2009	Differences in anti-phosphatidylserine-prothrombin complex antibodies and cutaneous vasculitis between regular livedo reticularis and livedo racemosa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshinao Soma Research Topics

Disease

11	Atopic Dermatitis (Atopic Eczema) 07/2017 - 01/2002
9	Polyarteritis Nodosa (Periarteritis Nodosa) 07/2017 - 12/2007
6	Vasculitis (Vasculitides) 10/2017 - 11/2007
5	Microscopic Polyangiitis 02/2014 - 01/2006
5	Pruritus (Itching) 06/2012 - 10/2003
4	Purpura 08/2011 - 04/2008
3	Eosinophilia 07/2013 - 05/2002
3	Vascular Skin Diseases 09/2011 - 05/2009
2	Inflammation (Inflammations) 02/2018 - 07/2017
2	Neoplasms (Cancer) 10/2017 - 05/2009
2	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2017 - 01/2006
2	Arteritis 08/2015 - 12/2013
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 07/2013 - 01/2006
2	Asthma (Bronchial Asthma) 07/2013 - 07/2005
2	Erythema elevatum diutinum 09/2011 - 12/2010
2	IgA Vasculitis (Purpura, Schoenlein Henoch) 08/2011 - 02/2010
2	Livedo Reticularis 03/2011 - 05/2009
2	Nephritis 12/2010 - 02/2010
2	Hypersensitivity (Allergy) 05/2009 - 01/2009
2	Behcet Syndrome (Behcet's Syndrome) 02/2009 - 05/2004
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2007 - 12/2005
2	Wounds and Injuries (Trauma) 10/2007 - 02/2002
1	Melanoma (Melanoma, Malignant) 04/2019
1	Thrombotic Microangiopathies 04/2019
1	Disseminated Intravascular Coagulation 04/2019
1	Drug Eruptions (Drug Eruption) 02/2018
1	Erythema 02/2018
1	Pigmentation Disorders (Ito Syndrome) 01/2018
1	Psoriatic Arthritis 07/2017
1	Necrosis 01/2017
1	Livedoid Vasculopathy 09/2015
1	Ulcer 09/2015
1	Erythrokeratodermia Variabilis 11/2014
1	pretibial Epidermolysis bullosa 11/2014
1	digital ulcers 02/2014
1	Arthritis (Polyarthritis) 12/2013
1	Edema (Dropsy) 12/2013
1	Mononeuropathies (Mononeuritis Multiplex) 12/2013
1	Pemphigus (Pemphigus Vulgaris) 11/2013
1	Dyschromatosis symmetrica hereditaria 1 09/2013
1	Renal Insufficiency (Renal Failure) 07/2013
1	Churg-Strauss Syndrome (Allergic Angiitis) 07/2013
1	Systemic Vasculitis 01/2013

Drug/Important Bio-Agent (IBA)

8	Prothrombin (Factor II)IBA 10/2017 - 12/2007
8	Immunoglobulin M (IgM)IBA 10/2017 - 12/2007
7	AntibodiesIBA 10/2017 - 12/2007
6	PhosphatidylserinesIBA 10/2017 - 12/2007
6	Antiphospholipid AntibodiesIBA 08/2011 - 12/2007
4	Therapeutic UsesIBA 09/2015 - 08/2008
4	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2014 - 02/2010
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 07/2013 - 01/2006
4	mizoribineIBA 09/2011 - 03/2009
4	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 08/2011 - 12/2007
3	Interleukin-13IBA 01/2017 - 01/2002
3	CytokinesIBA 01/2017 - 01/2002
3	AutoantibodiesIBA 11/2013 - 12/2005
3	AntigensIBA 09/2013 - 04/2005
3	Immunoglobulin G (IgG)IBA 02/2009 - 12/2007
2	moesinIBA 07/2017 - 01/2017
2	Messenger RNA (mRNA)IBA 07/2017 - 11/2014
2	Proteins (Proteins, Gene)FDA Link 07/2017 - 12/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2015 - 02/2014
2	Prednisolone (Predate)FDA LinkGeneric 12/2013 - 03/2011
2	Intravenous Immunoglobulins (IVIG)FDA Link 11/2013 - 01/2009
2	EmollientsIBA 05/2012 - 06/2011
2	Interleukin-6 (Interleukin 6)IBA 05/2012 - 09/2009
2	Peroxidase (Myeloperoxidase)IBA 09/2011 - 01/2006
2	Warfarin (Coumadin)FDA LinkGeneric 03/2011 - 10/2010
2	Immunoglobulin A (IgA)IBA 12/2010 - 04/2008
2	Antigen-Antibody Complex (Immune Complex)IBA 12/2010 - 11/2010
2	Histamine (Histamine Dihydrochloride)FDA Link 08/2006 - 10/2003
2	Tryptases (Tryptase)IBA 08/2006 - 10/2003
2	Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA 08/2006 - 10/2003
2	Histamine Antagonists (Antihistamines)IBA 08/2006 - 10/2003
1	trametinibIBA 04/2019
1	dabrafenibIBA 04/2019
1	NivolumabIBA 02/2018
1	Bovine Serum AlbuminIBA 01/2018
1	ChemokinesIBA 07/2017
1	Peptides (Polypeptides)IBA 07/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	InterferonsIBA 01/2017
1	InterleukinsIBA 01/2017
1	Vitamin A (Retinol)FDA LinkGeneric 11/2014
1	Biomarkers (Surrogate Marker)IBA 09/2014
1	Chemokine CCL17IBA 09/2014
1	Rituximab (Mabthera)FDA Link 02/2014
1	C-Reactive ProteinIBA 12/2013
1	Immunoglobulins (Immunoglobulin)IBA 11/2013
1	EnzymesIBA 11/2013
1	Desmoglein 1IBA 11/2013
1	ImmunosorbentsIBA 11/2013
1	Complement System Proteins (Complement)IBA 07/2013
1	NitrogenIBA 07/2013
1	Urea (Carbamide)FDA LinkGeneric 07/2013
1	bepotastine FDA Link 06/2012
1	bepotastine besilate FDA Link 06/2012

Therapy/Procedure

13	Therapeutics 04/2019 - 10/2003
1	Phototherapy (Light Therapy) 09/2013